13.09
前日終値:
$16.09
開ける:
$13.31
24時間の取引高:
1.98M
Relative Volume:
2.35
時価総額:
$1.02B
収益:
$1.64B
当期純損益:
$-495.80M
株価収益率:
-2.044
EPS:
-6.404
ネットキャッシュフロー:
$-45.25M
1週間 パフォーマンス:
-17.48%
1か月 パフォーマンス:
-20.87%
6か月 パフォーマンス:
+39.58%
1年 パフォーマンス:
-4.78%
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
名前
Integra Lifesciences Holdings Corp
セクター
電話
(609) 275-0500
住所
1100 CAMPUS ROAD, PRINCETON, NJ
Compare IART vs ABT, MDT, SYK, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
IART
Integra Lifesciences Holdings Corp
|
13.08 | 1.25B | 1.64B | -495.80M | -45.25M | -6.404 |
|
ABT
Abbott Laboratories
|
97.33 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
86.39 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
275.46 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
42.82 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
85.53 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-15 | ダウングレード | Argus | Buy → Hold |
| 2025-03-31 | アップグレード | Argus | Hold → Buy |
| 2024-12-02 | 開始されました | Morgan Stanley | Underweight |
| 2024-10-07 | アップグレード | BTIG Research | Sell → Neutral |
| 2024-07-30 | ダウングレード | BTIG Research | Neutral → Sell |
| 2024-07-30 | ダウングレード | Citigroup | Neutral → Sell |
| 2024-05-07 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2024-05-07 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-04-03 | アップグレード | Citigroup | Sell → Neutral |
| 2023-12-05 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-11-14 | 開始されました | CL King | Buy |
| 2023-08-24 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2023-07-12 | アップグレード | Jefferies | Hold → Buy |
| 2023-06-08 | ダウングレード | Argus | Buy → Hold |
| 2023-05-24 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2023-05-23 | ダウングレード | Citigroup | Neutral → Sell |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-07-25 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-04-13 | ダウングレード | Truist | Buy → Hold |
| 2021-12-17 | アップグレード | JP Morgan | Underweight → Neutral |
| 2021-09-15 | ダウングレード | BTIG Research | Buy → Neutral |
| 2020-10-08 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2020-05-27 | 開始されました | Citigroup | Neutral |
| 2020-04-03 | 開始されました | SunTrust | Buy |
| 2020-01-07 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2019-01-03 | 開始されました | SunTrust | Buy |
| 2018-11-28 | 開始されました | UBS | Neutral |
| 2018-08-07 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2018-07-26 | アップグレード | BTIG Research | Neutral → Buy |
| 2018-07-02 | ダウングレード | Citigroup | Buy → Neutral |
| 2018-01-05 | 再開されました | Cantor Fitzgerald | Neutral |
| 2018-01-02 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2017-11-09 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2017-10-30 | ダウングレード | Wells Fargo | Outperform → Market Perform |
| 2017-10-27 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2017-06-30 | 開始されました | Cantor Fitzgerald | Overweight |
| 2017-05-02 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2017-01-13 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2017-01-06 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-12-12 | 開始されました | UBS | Buy |
すべてを表示
Integra Lifesciences Holdings Corp (IART) 最新ニュース
IART vs. PEN: Which Stock Is the Better Value Option? - Zacks Investment Research
Integra LifeSciences Announces 100th Patient Enrolled in AERA® Pediatric Registry - Yahoo Finance
Integra LifeSciences Marks 20 Years of CUSA® Technology with Liver Surgery Education at ACS Clinical Congress 2026 - Yahoo Finance
Integra Lifesciences Holdings Corp (IART) Stock Down 3.1% -- Now Undervalued? GF Score: 70/100 - GuruFocus
Integra LifeSciences Holdings Corporation (IART) Stock Price, News, Quote & History - Yahoo! Finance Canada
Integra LifeSciences (IART) Stock May Be 48% Undervalued On Cash Flow - Yahoo Finance
A Look at Integra Lifesciences Holdings Corp (IART) After 6.1% D - GuruFocus
3 Reasons IART is Risky and 1 Stock to Buy Instead - Yahoo Finance
Integra LifeSciences on Track to Complete FDA Remediation in 2026 - Minichart
Integra LifeSciences to Present at the 2026 Wells Fargo Healthcare Conference and the 2026 Morgan Stanley Healthcare Conference - Yahoo Finance
Integra LifeSciences: Strong Q2 2026 Results Support Recovery Thesis (NASDAQ:IART) - Seeking Alpha
Integra LifeSciences Holdings (IART) Peer Comparison – Compare with Others - Value Research
Integra (IART) Down 1.6% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Integra LifeSciences (IART) Investors of Pending Securities Fraud Class Action, Encourages Investors with Substantial Losses to Contact Firm's Attorneys - TMX Newsfile
Can IART's SurgiMend Relaunch Help Drive a Broader 2027 Recovery? - Yahoo Finance
Is IART Still Attractive as Its Low Valuation Meets Execution Risks? - TradingView
Assenagon Asset Management S.A. Reduces Position in Integra LifeSciences Holdings Corporation $IART - MarketBeat
Integra LifeSciences /US Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Paradigm Capital discloses 4.42% Integra LifeSciences (IART) stake with sole voting control - Stock Titan
Integra LifeSciences (NASDAQ:IART) Stock Price Up 6.6%Time to Buy? - MarketBeat
Quantinno Capital Management LP Reduces Holdings in Integra LifeSciences Holdings Corporation $IART - MarketBeat
Integra LifeSciences Holdings Corporation (IART) Interactive Stock Chart - Yahoo! Finance Canada
5 Must-Read Analyst Questions From Integra LifeSciences’s Q2 Earnings Call - Yahoo Finance
Integra LifeSciences Holdings Corporation $IART Stock Position Trimmed by Dimensional Fund Advisors LP - MarketBeat
IART 10-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Integra LifeSciences (IART) Investors with Substantial Losses to Contact the Firm Before Nov. 13th Deadline in Securities Fraud Class Action - TMX Newsfile
Integra LifeSciences (IART) Declines 1.23% to $17.68 as Shares Test Key Support LevelRating Change - careplusvn.com
Glenmede Trust Co. NA Raises Stock Holdings in Integra LifeSciences Holdings Corporation $IART - MarketBeat
Healthcare of Ontario Pension Plan Trust Fund Sells 96,400 Shares of Integra LifeSciences Holdings Corporation $IART - MarketBeat
Integra LifeSciences Holdings (IART) Returns To Profit As Fair Value Debate Stays In Focus - Yahoo Finance
integra lifesciences holdings corp Profit Warnings - RTTNews
Access Investment Management LLC Buys 268,085 Shares of Integra LifeSciences Holdings Corporation $IART - MarketBeat
Vanguard Portfolio Management (IART) discloses 3.9M-share position in Integra - Stock Titan
Zacks.com featured highlights include Bassett Furniture, Aveanna Healthcare and Integra LifeSciences - Yahoo Finance
IART|Integra Lifesciences Holdings Corp|Price:18.245|Chg%:+0.005 - tradingkey.com
Integra Lifesciences Holdings Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Is Integra Lifesciences Holdings Corp (IART) Undervalued After Q - GuruFocus
Integra: Q2 Earnings Snapshot - kare11.com
Integra LifeSciences Reports Second Quarter 2026 Results, Updates Full-Year Revenue Guidance and Reaffirms EPS Outlook - Quiver Quantitative
Integra LifeSciences Reports Second Quarter 2026 Financial Results - Yahoo Finance Singapore
Earnings call transcript: Integra LifeSciences beats Q2 2026 EPS, shares fall premarket - Investing.com
Integra LifeSciences earnings up next: Can turnaround hold? - Investing.com
UBS initiates Integra LifeSciences stock with neutral rating - Investing.com
Integra LifeSciences (IART) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
Integra Lifesciences Holdings Corp (IART) Institutional Confidence - TradingKey
Integra Lifesciences Holdings Corp (IART) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Integra Lifesciences Holdings Corp (IART) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Integra Lifesciences Holdings Corp - TradingKey
Integra LifeSciences (NASDAQ:IART) Reaches New 12-Month HighShould You Buy? - MarketBeat
IART|Integra Lifesciences Holdings Corp|Price:19.530|Chg%:-0.260 - TradingKey
Integra Lifesciences Holdings Corp (IART) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
TradingKey - TradingKey
Integra Lifesciences Holdings Corp (IART) 財務データ
収益
当期純利益
現金流量
EPS
Integra Lifesciences Holdings Corp (IART) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Mar 10 '26 |
Option Exercise |
0.00 |
1,216 |
0 |
23,152 |
| Poul Mojdeh | President & CEO |
Jan 06 '26 |
Option Exercise |
0.00 |
1,390 |
0 |
1,390 |
| GRAVES JEFFREY A | Director |
Nov 05 '25 |
Buy |
11.35 |
9,000 |
102,150 |
41,086 |
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Oct 12 '25 |
Option Exercise |
0.00 |
11,965 |
0 |
25,217 |
大文字化:
|
ボリューム (24 時間):